The America's Most Reliable Companies 2025 rankings were identified from the results of an independent survey of more than 1,700 decision-makers who regularly do business with B2B companies and ...

Unknown to him he had been swallowing counterfeit tablets ... companies from Nigeria, a total of 105 local applications for the construction and erection of drug manufacturing facilities ...

The internet was flooded with iPad mini 7 reviews this week after Apple's quiet announcement of the mini tablet on October 15. Given it's been three years since we last saw Apple launch an 8.3 ...

One reason investors were impressed by Sanofi's latest fundamentals was the company's sales growth for the period. It came in at over 12% year over year, according to International Financial ...

Sanofi will keep a significant stake in the company to support Opella in their independence journey and to retain part of ...

It missed on sales, however. One reason investors were impressed by Sanofi's latest fundamentals was the company's sales growth for the period. It came in at over 12% year over year, according to ...

Chief executive officer Paul Hudson is ratcheting up Sanofi’s drug-development programme to create more medicines like Dupixent, which notched another quarter of record sales. The company is pushing a ...

the company raised its 2024 guidance for adjusted EPS growth to at least a low single-digit percentage, excluding sales from its Opella consumer healthcare division. Sanofi (SNY) is in discussions ...

Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company reported third ... which is responsible for manufacturing, additional capacity enabled increased ...

Oct 25 (Reuters) - French drug maker Sanofi (SASY.PA), opens new tab on ... estimate of 4 billion euros in a poll posted on the company's website. Vaccines sales rose a currency-adjusted 25.5 ...